+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The S-enantiomer of citalopram increases inhibitor binding to the human serotonin transporter by an allosteric mechanism Comparison with other serotonin transporter inhibitors



The S-enantiomer of citalopram increases inhibitor binding to the human serotonin transporter by an allosteric mechanism Comparison with other serotonin transporter inhibitors



European Neuropsychopharmacology 13(Suppl. 4): S215-S216




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035850040

Download citation: RISBibTeXText


Related references

The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors. European Neuropsychopharmacology 15(2): 193-198, 2005

R-citalopram decreases the association of -S-citalopram with the human serotonin transporter by an allosteric mechanism. European Neuropsychopharmacology 13(Suppl. 4): S217, 2003

Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding. Journal of Biological Chemistry 268(29): 21626-21631, 1993

An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant. Neuroscience Letters 462(3): 207-212, 2009

Characterization of an allosteric citalopram-binding site at the serotonin transporter. Journal of Neurochemistry 92(1): 21-28, 2004

Clickable photoaffinity ligands for the human serotonin transporter based on the selective serotonin reuptake inhibitor (S)-citalopram. Bioorganic and Medicinal Chemistry Letters 28(21): 3431-3435, 2018

Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram. Journal of Medicinal Chemistry 58(14): 5609-5619, 2015

No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse 48(4): 184-188, 2003

Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 25(6): 892-903, 2001

From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies. Journal of Medicinal Chemistry 51(10): 3045-3048, 2008

Differential mode of binding of imipramine and citalopram to the human serotonin transporter. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 371 6, 2003

The serotonin transporter in rhesus monkey brain: comparison of DASB and citalopram binding sites. Nuclear Medicine and Biology 33(4): 555-563, 2006

Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter. Journal of Biological Chemistry 285(3): 2051-2063, 2010

Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI). Psychopharmacology 166(3): 294-297, 2003

Y95 and E444 interaction required for high-affinity S-citalopram binding in the human serotonin transporter. Acs Chemical Neuroscience 2(2): 75-81, 2011